JIANG Youfan, et al. Comparative study of gemcitabine plus CBP and navelbine plus DDP regimen in the treatment of old patients with age NSCLC. [J]. Journal of Chongqing Medical University (1):85-87(2006)
JIANG Youfan, et al. Comparative study of gemcitabine plus CBP and navelbine plus DDP regimen in the treatment of old patients with age NSCLC. [J]. Journal of Chongqing Medical University (1):85-87(2006)DOI:
Comparative study of gemcitabine plus CBP and navelbine plus DDP regimen in the treatment of old patients with age NSCLC
Objective: To evaluate and compare the effects and safety of GC(GEZ+CBP) regimen and NP(NVB=DDP) regimen for old age patients with advancde non-small cell lung cancer(NSCLC).Methods: The 40 cases of old age patients with advancde NSCLC were randomly divided into GC regimen group and NP regimen group
twenty cases of each group respectively received GEM+CBP regimen and NVB+DDP regimen.The patients received GEM 1000mg/m2 on 1st and 8th day and CBP 300 mg/m2 on 1st day.NVB 25mg/m2 on 1st and 8th day and DDP 80mg/m2 with 1st and 3th day.Course was repeated every 3 weeks.Results: The response rate(CR+PR) were 40% and 35% respectively for GEM and NVB groups.There was no significant difference existed between the two groups(P>0.05)
and also the MST
DPT and one-year survival rate(P>0.05).But the rates of thrombocytopenia and phlebitis in GEM group were significantly lower than NVB group.Conclusions: The short-time clinical efficacy
MST
DPT and one-year survival rate of GEM+CBP regimen were similar to those of NVB+DDP regimen
but the toxicity of GEM+CBP regimen were lower than those of NVB+DDP regimen.The GC regimen is a safe and effective regimen for old age advancde NSCLC.
The combined chemotherapy of ifosfamide plus vindesine and cisplatin in advanced non-small cell lung cancer
Different doses of gemcitabine chemotherapy after radical resection of pancreatic cancer:a randomized controlled clinical study
Advances in immunotherapy in EGFR-mutated non-small cell lung cancer
Comparison of the clinical efficacy of Disitamab Vedotin and postoperative chemotherapy in the treatment of HER-2 positive locally advanced urothelial carcinoma
Efficacy of transurethral submucosal dissection of bladder tumor combined with intraoperative bladder submucosal injection of gemcitabine in treatment of non-muscle invasive urothelial bladder cancer: a report of seven cases
Related Author
HUANG Shicong
et al
YU Xu-ping
Wei Kunchen
Wu Junfeng
Tang Hao
Xu Qiao
Jiang Yu
Related Institution
Department of Respiratory Diseases,College of Clinical Medicine,Chongqing Medical University
重庆医科大学临床学院肺科
Department of Surgery,Shaoyang Central Hospital of Hunan Province
Beijing Garrison District Haidian 40th Separation Cadre Retreat
Department of Respiratory and Critical Care Medicine,Shanghai Changzheng Hospital